Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

Joe O'Sullivan, R.A. Huddart, A.R. Norman, J. Nicholls, D.P. Dearnaley, A. Horwich

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include cumulative bleomycin dose, reduced glomerular filtration rate (GFR), raised creatinine, older age and supplemental oxygen exposure.
Original languageEnglish
Pages (from-to)91-96
Number of pages6
JournalAnnals of Oncology
Volume14
Issue number1
DOIs
Publication statusPublished - 01 Jan 2003

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours'. Together they form a unique fingerprint.

Cite this